Interleukin-6 Antibody Inflammation Trial: TRANQUILITY Explained
Published on: 05/10/2026
The interleukin-6 antibody inflammation trial TRANQUILITY cut hsCRP by up to 89% over six months. Learn what the phase 2 results show, and what they don't. Read the full analysis.
interleukin-6 antibody inflammation trial
Zitroz Inc. 3855 Main St Chula Vista, CA 91911. USA
PrecisionBio by Zitroz Medico S.A.P.I. de C.V. © 2026. - All Rights Reserved.